HomeREGENTIS BIOMATERIALS

REGENTIS BIOMATERIALS

Regentis Expands SAGE Clinical Trial Study of GelrinC for Damaged Articular Cartilage

Regentis Biomaterials today announced it has expanded the SAGE clinical trial of GelrinCâ„¢ for the treatment of articular cartilage damage in the knee to 11 U.S. sites. GelrinC is an investigational device being evaluated as a treatment...